4049 – PmSclplus Dot

Intended Purpose

The PmSclplus Dot is a qualitative dot immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens (Jo-1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl 100 and
Scl-70) in human serum. The PmSclplus is intended as an aid in the diagnosis of systemic autoimmune diseases in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.


Diagnostic Relevance

Progressive systemic sclerosis (PSS) or systemic scleroderma is an autoimmune disease of connective tissue characterized by slowly progressive fibrosis leading to sclerosis. Scl-70 autoantibodies are pathognomonic for PSS patients.

Polymyositis and dermatomyositis are idiopathic inflammatory muscle disorders with an unknown etiology, however, autoantibodies to t-RNA transferases like Jo-1, PL-7, and PL-12 are found in myositis patients. Antibodies to SRP are also specific markers for Polymyositis. Mi-2 autoantibodies are detected almost exclusively in patients with dermatomyositis. Patients tested positive for Mi-2 have a relatively mild clinical course.

Product Specifications

Title PmSclplus Dot
Product code 4049
Indication Systemic autoimmune diseases
Description Dot Immunoassay for the qualiative determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum
Format Test strips coated with Jo-1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl 100 and Scl-70
Total incubation time 80 min.
Sample volume 10 ┬ÁL serum
No. of determinations 24 x 8

Free downloads

  SDS [REF 4049][eng]   SDS [REF 4049][deu]

Restricted downloads - Password required

Current version of the instructions for use. The respective valid version for processing the test can be found in the product packaging.